This inventor holds 2 USPTO granted patents. Top assignees: Dic Corporation, Kawamura Institute of Chemical Research. Active years: 2016-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 811 
1 out of 42 Years Active: 2016-2022
Title: Noriko Santou: Innovator in Cell Culture and Antithrombotic Technologies
Introduction
Noriko Santou is a prominent inventor based in Sakura, Japan. She has made significant contributions to the fields of cell culture and medical coatings, holding a total of 2 patents. Her innovative work focuses on developing advanced materials that enhance biological applications.
Latest Patents
One of her latest patents is a cell culture substrate that includes a polymer with a lower critical solution temperature. This substrate incorporates inorganic materials such as water-swellable clay minerals and silica, along with an adhesive matrix that can be an extracellular matrix or an adhesive synthetic matrix. The extracellular matrix may consist of components like laminin, fibronectin, vitronectin, cadherin, and their fragments. Additionally, the adhesive synthetic matrix can be poly[2-(methacryloyloxy)ethyl dimethyl-(3-sulfopropyl) ammonium hydroxide] or an oligopeptide-supporting polymer.
Another notable patent involves a block copolymer and an antithrombotic coating agent. This invention provides a copolymer with excellent coating formation ability and adhesive properties, which does not adsorb proteins. The antithrombotic coating agent demonstrates superior properties compared to conventional agents, and it is designed for use in medical instruments.
Career Highlights
Throughout her career, Noriko Santou has worked with notable organizations, including Dic Corporation and the Kawamura Institute of Chemical Research. Her experience in these institutions has allowed her to refine her expertise in polymer science and medical applications.
Collaborations
Noriko has collaborated with esteemed colleagues such as Tetsuo Takada and Naoto Sakurai. These partnerships have contributed to her innovative research and development efforts.
Conclusion
Noriko Santou is a trailblazer in the field of biomedical innovations, particularly in cell culture substrates and antithrombotic technologies. Her patents reflect her commitment to advancing medical science through innovative materials.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile